But an experimental outpatient gut procedure might help people transition off their GLP-1 weight loss drug without packing on the pounds, according to new research scheduled for presentation at the Digestive Disease Week meeting in Chicago
For CY 2026, consistent with our established policy, we proposed in the CY 2026 OPPS/ASC proposed rule (90 FR 33533) that the HCPCS codes that would be effective October 1, 2025, would be flagged with comment indicator N1 in Addendum B to the CY 2026 OPPS/ASC final rule with comment period to indicate that we have assigned the codes to interim OPPS status indicators for CY 2026
The weight-loss drug triggered a mental health crisis that really shook her in December 2025
Because of its triple-action mechanism, it appears to have a broader metabolic impact compared with traditional GLP-1 agonists like Wegovy and Mounjaro
Zudem werden keine Rohstoffe verwendet, die gentechnisch verndert, bestrahlt oder mit Ethylenoxid behandelt wurden